Human papillomavirus vaccination for men who have sex with men in China: demand and suggestions

VernacularTitle:我国男男性行为人群中人乳头瘤病毒疫苗接种的需求与建议
Author: Xin LIU ¹ ; Ling ZHANG ; Shu JING ; Yijin WU ; Xiaoyou SU ; Youlin QIAO
Author Information

1. 中国医学科学院北京协和医学院群医学及公共卫生学院，北京　100730
Keywords: Men who have sex with men; Human papillomavirus; Vaccination
From: Chinese Journal of Epidemiology 2023;44(8):1321-1326
CountryChina
Language:Chinese
Abstract: MSM are a high-risk population for HPV infection and related diseases. MSM can be effectively protected by quadrivalent and nine-valent HPV vaccines. This paper outlines the significance of providing HPV vaccination to MSM, summarizes the basis of HPV vaccination in MSM, and puts forward the following recommendations. First, China should expedite the development and approval of the HPV vaccine for male use. Second, HIV-positive MSM should vaccinate against HPV as soon as possible. Third, prioritize HPV vaccination for MSM individuals aged 26 or less. Fourth, for MSM aged over 26, catch-up vaccination or opportunistic vaccination should be provided when HPV vaccine resources are sufficient. Implementing this vaccination strategy can provide protection for the MSM and control the spread of sexually transmitted diseases.